Soleno Therapeutics, Inc. (SLNO) Social Stream



Soleno Therapeutics, Inc. (SLNO): $46.16

0.50 (+1.10%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add SLNO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#275 of 362

in industry

SOLENO THERAPEUTICS INC (SLNO) Price Targets From Analysts

Use the tables below to see what analysts covering SOLENO THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-27 1 $5 $5 $5 $36.7 -86.38%
2022-07-20 1 $3 $3 $3 $36.7 -91.83%
2022-08-10 1 $29.985 $29.985 $29.985 $36.7 -18.3%
2023-05-10 1 $8 $8 $8 $36.7 -78.2%
2023-08-21 2 $19 $8 $13.5 $36.7 -63.22%
2023-09-15 2 $19 $14 $16.5 $36.7 -55.04%
2023-09-27 2 $39 $35 $37 $36.7 0.82%
2023-10-05 2 $39 $33 $36 $36.7 -1.91%
2023-11-03 2 $59 $39 $49 $36.7 33.51%
2023-11-10 3 $59 $44 $51.5 $36.7 40.33%
2023-12-11 3 $59 $40 $47.666 $36.7 29.88%

The Trend in the Analyst Price Target


SLNO's average price target has moved up $44.67 over the prior 21 months.

SLNO reports an average of 133.12% for its upside potential over the past 38 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-10 2 8 8 8.000 4.05 97.53%
2023-05-10 1 8 8 8.000 4.05 97.53%
2023-07-11 2 19 8 13.500 4.89 176.07%
2023-10-05 2 39 33 36.000 23.81 51.2%
2023-12-11 3 59 40 47.666 35.50 34.27%

SLNO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 122 days, SLNO's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SLNO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, SOLENO THERAPEUTICS INC's number of analysts covering the stock is higher than 34.57% of them.
  • In the context of stocks in the small market cap category, SOLENO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 174.39% of them.
  • In the context of Healthcare stocks, SOLENO THERAPEUTICS INC's variance in analysts' estimates is lower than -116.05% of them.
  • SLNO has a higher average analyst price target than 735.67% of stocks in the small market cap category.

In the Medical Equipment industry, PROF, RCEL, and XAIR are the three stocks most similar to SOLENO THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is SLNO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!